How do gastroenterology billing specialists handle prior authorization denials for high-cost GI biologics and chronic inflammatory bowel disease specialty infusions?

[Dr.EmmaRichardson]

Gastroenterology practices experience significant revenue delays and patient care disruptions due to complex prior authorization ¶ requirements for biologic therapies (e.g., infliximab, vedolizumab). Payers frequently issue retroactive rejections or demand extensive step-therapy documentation, leaving clinics with unpaid drug and administration claims.

[Edward_Palmer]

Don’t sleep on peer-to-peer prep sheets! We list exact failure dates for conventional meds right at the top so our GI docs hit key endpoints during their quick 5-minute call.

[NathanielBrooks-34]

Also, don’t forget reauthorization timing! Set automatic 60-day alerts before PA expiration dates so maintenance doses don’t get hit with retroactive denials. Running a quick re-verify right before mixing specialty infusions saves thousands! clinic-side.